Device Trial Radar · NCT05073510
Clinical Evaluation of the BlueDop Vascular Expert for Assessing Peripheral Arterial Disease
Last checked: Nov 20, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
187
Actual
Start
Oct 11, 2021
Primary completion
Sep 11, 2023
Study completion Sep 11, 2023
Sponsor
- Lead sponsor
- BlueDop Medical LTDNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- AKRN Scientific Consulting, S.L.
- First posted
- Oct 11, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a BlueDop Vascular Expert System (BVE) Post-Market Clinical Follow-Up (PMCF) study. The primary objective of the study is to assess the clinical applicability and diagnostic accuracy of the BVE device in subjects who require an arterial duplex test due to suspected peripheral arterial disease (PAD).
Conditions
- Peripheral Arterial Disease
Interventions
BVEDevice
Participants will undergo BVE evaluation for assessing Peripheral Arterial Disease (PAD)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determination of Presence or Absence of Significant PAD With BVE and Arterial DuplexTime frame: 1 day
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Clínica Universidad de Navarra
Madrid, Spain
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.